PDB Short entry for 2LNS HEADER ISOMERASE 04-JAN-12 2LNS TITLE SOLUTION STRUCTURE OF AGR2 RESIDUES 41-175 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANTERIOR GRADIENT PROTEIN 2 HOMOLOG; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 41-175; COMPND 5 SYNONYM: AG-2, HAG-2, HPC8, SECRETED CEMENT GLAND PROTEIN XAG-2 COMPND 6 HOMOLOG; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AGR2, AG2, UNQ515/PRO1030; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PET-151D KEYWDS ANTERIOR-GRADIENT PROTEIN 2, THIOREDOXIN-FOLD, CANCER, ADHESION, KEYWDS 2 METASTASIS, ISOMERASE EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR P.PATEL,C.J.CLARKE,D.L.BARRACLOUGH,P.S.RUDLAND,R.BARRACLOUGH,L.LIAN REVDAT 4 14-JUN-23 2LNS 1 REMARK SEQADV REVDAT 3 06-MAR-13 2LNS 1 JRNL REVDAT 2 30-JAN-13 2LNS 1 JRNL REVDAT 1 09-JAN-13 2LNS 0 JRNL AUTH P.PATEL,C.CLARKE,D.L.BARRACLOUGH,T.A.JOWITT,P.S.RUDLAND, JRNL AUTH 2 R.BARRACLOUGH,L.Y.LIAN JRNL TITL METASTASIS-PROMOTING ANTERIOR GRADIENT 2 PROTEIN HAS A JRNL TITL 2 DIMERIC THIOREDOXIN FOLD STRUCTURE AND A ROLE IN CELL JRNL TITL 3 ADHESION. JRNL REF J.MOL.BIOL. V. 425 929 2013 JRNL REFN ISSN 0022-2836 JRNL PMID 23274113 JRNL DOI 10.1016/J.JMB.2012.12.009 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNSSOLVE, CNSSOLVE REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 (CNSSOLVE), BRUNGER, ADAMS, CLORE, GROS, NILGES REMARK 3 AND READ (CNSSOLVE) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2LNS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-JAN-12. REMARK 100 THE DEPOSITION ID IS D_1000102610. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : 0.1 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1 MM [U-13C; U-15N; U-2H] AGR2, REMARK 210 90% H2O/10% D2O; 1 MM [U-15N; REMARK 210 ILED1-[13CH3]; LEU,VAL-[13CH3]] REMARK 210 AGR2, 90% H2O/10% D2O; 1 MM [U- REMARK 210 15N] AGR2, 10 MG PF1 PHAGE, 90% REMARK 210 H2O/10% D2O; 1 MM [U-15N] AGR2, REMARK 210 5 % PEG:HEXANOL, PEG REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC; REMARK 210 3D HN(COCA)CB; 3D HNCO; 3D HNCA; REMARK 210 3D HNCACB; 3D HN(CO)CA; 3D 1H- REMARK 210 15N NOESY; 3D 1H-13C NOESY; IPAP; REMARK 210 3D HN(CA)CO REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : ANALYSIS, TOPSPIN REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 300 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HE ARG A 148 OD1 ASP A 156 1.58 REMARK 500 HE ARG B 148 OD1 ASP B 156 1.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PRO A 38 -156.78 -73.03 REMARK 500 1 THR A 40 90.50 38.77 REMARK 500 1 PRO A 41 10.57 -54.77 REMARK 500 1 ARG A 46 11.61 49.24 REMARK 500 1 TRP A 48 -75.56 -77.14 REMARK 500 1 ASP A 50 -38.84 -33.57 REMARK 500 1 LEU A 52 171.60 65.11 REMARK 500 1 THR A 57 134.98 69.27 REMARK 500 1 TYR A 58 -71.34 -53.75 REMARK 500 1 GLU A 59 -68.25 -26.89 REMARK 500 1 PRO A 82 -10.26 -45.62 REMARK 500 1 LYS A 89 -76.58 -66.29 REMARK 500 1 ASN A 94 68.27 -67.91 REMARK 500 1 LYS A 99 -36.10 -35.39 REMARK 500 1 PHE A 104 -155.49 -137.61 REMARK 500 1 THR A 113 -39.67 -161.43 REMARK 500 1 THR A 114 81.71 -66.81 REMARK 500 1 ASP A 115 143.57 -39.74 REMARK 500 1 LYS A 116 9.36 -61.50 REMARK 500 1 SER A 119 117.87 -161.08 REMARK 500 1 PRO A 120 -88.28 -55.23 REMARK 500 1 TYR A 124 -163.80 -76.13 REMARK 500 1 VAL A 125 -67.20 -91.76 REMARK 500 1 PRO A 126 82.30 -51.89 REMARK 500 1 ARG A 127 76.30 -118.43 REMARK 500 1 PRO A 133 -19.67 -48.57 REMARK 500 1 LEU A 135 33.52 70.08 REMARK 500 1 VAL A 137 79.00 -65.77 REMARK 500 1 SER A 146 -4.77 -55.54 REMARK 500 1 LEU A 149 12.45 -59.11 REMARK 500 1 ALA A 151 75.07 -106.82 REMARK 500 1 TYR A 152 80.06 -47.70 REMARK 500 1 THR A 157 -27.82 -36.27 REMARK 500 1 LEU A 171 -21.96 -141.49 REMARK 500 1 THR A 173 -63.45 -150.99 REMARK 500 1 PRO B 38 -158.82 -72.58 REMARK 500 1 THR B 40 93.24 43.44 REMARK 500 1 PRO B 41 14.31 -58.19 REMARK 500 1 ARG B 46 -65.46 68.52 REMARK 500 1 ASP B 50 -35.35 -35.66 REMARK 500 1 LEU B 52 167.57 83.03 REMARK 500 1 THR B 57 131.75 78.30 REMARK 500 1 TYR B 58 -71.48 -54.50 REMARK 500 1 GLU B 59 -65.13 -29.99 REMARK 500 1 PRO B 82 -18.70 -41.23 REMARK 500 1 LYS B 89 -77.44 -66.36 REMARK 500 1 ASN B 94 68.26 -67.99 REMARK 500 1 LYS B 99 -35.84 -35.63 REMARK 500 1 PHE B 104 -156.73 -136.94 REMARK 500 1 THR B 113 -37.62 -161.51 REMARK 500 REMARK 500 THIS ENTRY HAS 614 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 18178 RELATED DB: BMRB REMARK 900 RELATED ID: 2LNT RELATED DB: PDB DBREF 2LNS A 41 175 UNP O95994 AGR2_HUMAN 41 175 DBREF 2LNS B 41 175 UNP O95994 AGR2_HUMAN 41 175 SEQADV 2LNS ILE A 36 UNP O95994 EXPRESSION TAG SEQADV 2LNS ASP A 37 UNP O95994 EXPRESSION TAG SEQADV 2LNS PRO A 38 UNP O95994 EXPRESSION TAG SEQADV 2LNS PHE A 39 UNP O95994 EXPRESSION TAG SEQADV 2LNS THR A 40 UNP O95994 EXPRESSION TAG SEQADV 2LNS ILE B 36 UNP O95994 EXPRESSION TAG SEQADV 2LNS ASP B 37 UNP O95994 EXPRESSION TAG SEQADV 2LNS PRO B 38 UNP O95994 EXPRESSION TAG SEQADV 2LNS PHE B 39 UNP O95994 EXPRESSION TAG SEQADV 2LNS THR B 40 UNP O95994 EXPRESSION TAG SEQRES 1 A 140 ILE ASP PRO PHE THR PRO GLN THR LEU SER ARG GLY TRP SEQRES 2 A 140 GLY ASP GLN LEU ILE TRP THR GLN THR TYR GLU GLU ALA SEQRES 3 A 140 LEU TYR LYS SER LYS THR SER ASN LYS PRO LEU MET ILE SEQRES 4 A 140 ILE HIS HIS LEU ASP GLU CYS PRO HIS SER GLN ALA LEU SEQRES 5 A 140 LYS LYS VAL PHE ALA GLU ASN LYS GLU ILE GLN LYS LEU SEQRES 6 A 140 ALA GLU GLN PHE VAL LEU LEU ASN LEU VAL TYR GLU THR SEQRES 7 A 140 THR ASP LYS HIS LEU SER PRO ASP GLY GLN TYR VAL PRO SEQRES 8 A 140 ARG ILE MET PHE VAL ASP PRO SER LEU THR VAL ARG ALA SEQRES 9 A 140 ASP ILE THR GLY ARG TYR SER ASN ARG LEU TYR ALA TYR SEQRES 10 A 140 GLU PRO ALA ASP THR ALA LEU LEU LEU ASP ASN MET LYS SEQRES 11 A 140 LYS ALA LEU LYS LEU LEU LYS THR GLU LEU SEQRES 1 B 140 ILE ASP PRO PHE THR PRO GLN THR LEU SER ARG GLY TRP SEQRES 2 B 140 GLY ASP GLN LEU ILE TRP THR GLN THR TYR GLU GLU ALA SEQRES 3 B 140 LEU TYR LYS SER LYS THR SER ASN LYS PRO LEU MET ILE SEQRES 4 B 140 ILE HIS HIS LEU ASP GLU CYS PRO HIS SER GLN ALA LEU SEQRES 5 B 140 LYS LYS VAL PHE ALA GLU ASN LYS GLU ILE GLN LYS LEU SEQRES 6 B 140 ALA GLU GLN PHE VAL LEU LEU ASN LEU VAL TYR GLU THR SEQRES 7 B 140 THR ASP LYS HIS LEU SER PRO ASP GLY GLN TYR VAL PRO SEQRES 8 B 140 ARG ILE MET PHE VAL ASP PRO SER LEU THR VAL ARG ALA SEQRES 9 B 140 ASP ILE THR GLY ARG TYR SER ASN ARG LEU TYR ALA TYR SEQRES 10 B 140 GLU PRO ALA ASP THR ALA LEU LEU LEU ASP ASN MET LYS SEQRES 11 B 140 LYS ALA LEU LYS LEU LEU LYS THR GLU LEU HELIX 1 1 THR A 57 THR A 67 1 11 HELIX 2 2 CYS A 81 ALA A 92 1 12 HELIX 3 3 ASN A 94 GLN A 103 1 10 HELIX 4 4 ASP A 156 LEU A 168 1 13 HELIX 5 5 THR B 57 THR B 67 1 11 HELIX 6 6 CYS B 81 ALA B 92 1 12 HELIX 7 7 ASN B 94 GLN B 103 1 10 HELIX 8 8 ASP B 156 LEU B 168 1 13 SHEET 1 A 2 LEU A 72 HIS A 76 0 SHEET 2 A 2 ARG A 127 VAL A 131 -1 O MET A 129 N ILE A 74 SHEET 1 B 2 LEU B 72 HIS B 76 0 SHEET 2 B 2 ARG B 127 VAL B 131 -1 O MET B 129 N ILE B 74 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000